Total Payments
$12,260
2021 Payments
$10,283
Companies
5
Transactions
11
Medicare Patients
859
Medicare Billing
$76,795

Payment Breakdown by Category

Consulting$6,000 (48.9%)
Other$2,475 (20.2%)
Research$1,863 (15.2%)
Travel$1,409 (11.5%)
Food & Beverage$474.58 (3.9%)
Education$38.00 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $6,000 1 48.9%
Honoraria $2,475 1 20.2%
Unspecified $1,863 3 15.2%
Travel and Lodging $1,409 2 11.5%
Food and Beverage $474.58 3 3.9%
Education $38.00 1 0.3%

Payments by Type

General
$10,397
8 transactions
Research
$1,863
3 transactions

Top Paying Companies

Company Total Records Latest Year
Chiasma, Inc. $7,808 5 $0 (2021)
RECORDATI_RARE_DISEASES_INC. $2,475 1 $0 (2021)
NOVARTIS PHARMACEUTICALS CORPORATION $1,863 3 $0 (2017)
PFIZER INC. $75.65 1 $0 (2019)
Corcept Therapeutics $38.00 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2021 $10,283 6 Chiasma, Inc. ($7,808)
2019 $75.65 1 PFIZER INC. ($75.65)
2018 $38.00 1 Corcept Therapeutics ($38.00)
2017 $1,863 3 NOVARTIS PHARMACEUTICALS CORPORATION ($1,863)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/11/2021 RECORDATI_RARE_DISEASES_INC. Honoraria Cash or cash equivalent $2,475.00 General
07/06/2021 Chiasma, Inc. MYCAPSSA (Drug) Consulting Fee Cash or cash equivalent $6,000.00 General
Category: Endocrinology
07/06/2021 Chiasma, Inc. MYCAPSSA (Drug) Food and Beverage Cash or cash equivalent $81.14 General
Category: Endocrinology
06/25/2021 Chiasma, Inc. MYCAPSSA (Drug) Travel and Lodging In-kind items and services $948.40 General
Category: Endocrinology
06/25/2021 Chiasma, Inc. MYCAPSSA (Drug) Travel and Lodging In-kind items and services $460.68 General
Category: Endocrinology
06/25/2021 Chiasma, Inc. MYCAPSSA (Drug) Food and Beverage In-kind items and services $317.79 General
Category: Endocrinology
03/22/2019 PFIZER INC. SOMAVERT (Drug) Food and Beverage In-kind items and services $75.65 General
Category: ENDOCRINE DISEASE;METABOLIC DISEASE
09/13/2018 Corcept Therapeutics Korlym (Drug) Education In-kind items and services $38.00 General
Category: Endocrinology
04/02/2017 NOVARTIS PHARMACEUTICALS CORPORATION SIGNIFOR (Drug) In-kind items and services $418.94 Research
Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: ONCOLOGY
04/02/2017 NOVARTIS PHARMACEUTICALS CORPORATION SIGNIFOR (Drug) In-kind items and services $335.15 Research
Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: ONCOLOGY
01/11/2017 NOVARTIS PHARMACEUTICALS CORPORATION SIGNIFOR (Drug) In-kind items and services $1,108.82 Research
Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: ONCOLOGY

Research Studies & Clinical Trials

Study Name Company Amount Records
RESEARCH RELATED PUBLICATION SUPPORT NOVARTIS PHARMACEUTICALS CORPORATION $1,863 3

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 194 218 $51,910 $17,455
2022 6 243 260 $66,188 $21,156
2021 7 233 272 $70,005 $22,393
2020 5 189 231 $64,340 $15,790
Total Patients
859
Total Services
981
Medicare Billing
$76,795
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 72 87 $16,360 $5,625 34.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 41 45 $8,190 $3,238 39.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 27 30 $8,022 $2,962 36.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 17 19 $4,636 $2,128 45.9%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 21 21 $5,662 $1,873 33.1%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 16 16 $9,040 $1,629 18.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 56 61 $12,014 $4,366 36.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 36 44 $12,316 $3,919 31.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 51 55 $10,238 $3,733 36.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 26 26 $6,344 $2,644 41.7%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 22 22 $11,440 $2,320 20.3%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 15 15 $5,175 $2,014 38.9%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 21 21 $6,436 $1,828 28.4%
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report Facility 2022 16 16 $2,225 $332.36 14.9%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 80 96 $17,472 $6,820 39.0%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 30 36 $8,784 $3,996 45.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 33 39 $10,666 $2,718 25.5%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 17 17 $7,108 $1,956 27.5%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 13 13 $4,485 $1,857 41.4%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 17 17 $8,670 $1,818 21.0%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 16 16 $4,720 $1,535 32.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 16 22 $5,940 $1,244 20.9%
95251 Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours Facility 2021 11 16 $2,160 $449.28 20.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 82 100 $18,403 $5,599 30.4%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 30 30 $14,550 $3,266 22.4%

About Dr. Ismat Shafiq, MD

Dr. Ismat Shafiq, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1104093988.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ismat Shafiq, MD has received a total of $12,260 in payments from pharmaceutical and medical device companies, with $10,283 received in 2021. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($6,000).

As a Medicare-enrolled provider, Shafiq has provided services to 859 Medicare beneficiaries, totaling 981 services with total Medicare billing of $76,795. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

Products in Payments

  • MYCAPSSA (Drug) $7,808
  • SIGNIFOR (Drug) $1,863
  • SOMAVERT (Drug) $75.65
  • Korlym (Drug) $38.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Rochester